Overview

Dexamethasone at Lower Concentration Ropivacaine in the Supraclavicular Nerve Block

Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
0
Participant gender:
All
Summary
The supraclavicular brachial plexus block is widely used in upper limb surgery below the shoulder. However, this can easily lead to long-term motor nerve blockage, Horner's syndrome, phrenic nerve paralysis or systemic poisoning, and even serious side effects such as cardiac arrest. Dexamethasone is a synthetic corticosteroid and becoming more common to use steroids as an adjunct to local anesthetics in brachial plexus block. In order to reduce the incidence of long-acting topical anesthetics from the nerve block in the supraclavicular arm, reducing the local anesthetic concentration is a feasible method, but this will also result in a shorter time to neurological block. The investigators hypothesized that the addition of Dexamethasone 5 mg to low concentrations (0.25%) of Ropivacaine would prolong postoperative analgesia.Therefore, the purpose of this study was to compare the postoperative analgesia and the side effects of postoperative supraclavicular brachial plexus blockade with the addition of Dexamethasone 5mg to Ropivacaine (0.5%) alone and Ropivacaine (0.25%) in low concentrations.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Treatments:
BB 1101
Dexamethasone
Dexamethasone acetate
Ropivacaine
Criteria
Inclusion Criteria:

- American society of Anesthesiology classification: I ~ III

- patients who have undergone arm surgery for blockage of the upper clavicle from nerve
block

Exclusion Criteria:

- Patients had brachial plexus degeneration, coagulation abnormalities, obvious heart,
lung, liver or kidney disease, body mass index less than 18.5 or greater than 35, body
weight greater than 80 kg, pregnancy, regular use of steroids or opiates Opioids,
chronic medication or alcohol abuse, as well as previous allergies or adverse
reactions to opiates, dexamethasone, or the use of topical anesthetic Ropivacaine,
were excluded from this study.